Showing results (81-90 of 100) with videos related to
Sort By:
Pageof 10
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|May 13, 2024
Discordant and Concordant Substance Use and Daily Partner Violence in Adolescent and Young Adult Relationships With Baseline Dating ViolenceTiffany E Mark, Megan H Bair-Merritt, Shang-En Chung, et al.BMC Cancer|January 9, 2019
Patients with metastatic renal cell carcinoma who benefit from axitinib dose titration: analysis from a randomised, double-blind phase II studyYoshihiko Tomita, Hirotsugu Uemura, Mototsugu Oya, et al.Public Health Reports (Washington, D.C. : 1974)|July 7, 2016
Identifying Challenges to the Integration of Computer-Based Surveillance Information Systems in a Large City Health Department: A Case StudyJacky M Jennings, Jeffrey A Stover, Megan H Bair-Merritt, et al.American Journal of Preventive Medicine|August 23, 2015
Adverse Childhood Experiences: Expanding the Concept of AdversityPeter F Cronholm, Christine M Forke, Roy Wade, et al.Journal of Addiction Medicine|October 16, 2020
A Retrospective Cohort Study Examining the Utility of Perinatal Urine Toxicology Testing to Guide Breastfeeding InitiationMiriam Harris, Kathleen Joseph, Bettina Hoeppner, et al.Child Abuse & Neglect|January 5, 2016
Household and community-level Adverse Childhood Experiences and adult health outcomes in a diverse urban populationRoy Wade, Peter F Cronholm, Joel A Fein, et al.Cancer Science|March 8, 2017
Overall survival of first-line axitinib in metastatic renal cell carcinoma: Japanese subgroup analysis from phase II studyMototsugu Oya, Yoshihiko Tomita, Satoshi Fukasawa, et al.Clinical Genitourinary Cancer|August 8, 2016
Axitinib Versus Sorafenib in First-Line Metastatic Renal Cell Carcinoma: Overall Survival From a Randomized Phase III TrialThomas E Hutson, Salman Al-Shukri, Viktor P Stus, et al.Journal of Family Violence|June 21, 2021
Adolescent and Young Women's Daily Reports of Emotional Context and Episodes of Dating ViolencePamela A Matson, Ty A Ridenour, Shang-En Chung, et al.The Lancet. Oncology|November 12, 2013
Axitinib versus sorafenib as first-line therapy in patients with metastatic renal-cell carcinoma: a randomised open-label phase 3 trialThomas E Hutson, Vladimir Lesovoy, Salman Al-Shukri, et al.Pageof 10